Aptevo Therapeutics (APVO) EBITDA Margin (2015 - 2022)
Aptevo Therapeutics' EBITDA Margin came in at -890.82% for FY2022, down 726.03 percentage points from -164.79% in FY2021.
Powered by 
Analysis
Aptevo Therapeutics (APVO) EBITDA Margin (2015 - 2022) Analysis & Trends
Going back to FY2015, Aptevo Therapeutics' EBITDA Margin data covers 8 years.
- EBITDA Margin carries a five-year change of -544.10 percentage points (FY2017 to FY2022).
- The FY2022 figure represents the lowest annual EBITDA Margin since FY2016.
- Per Business Quant, earlier years put EBITDA Margin at -164.79% in FY2021 (+440.64 pp), -605.43% in FY2020 (-485.99 pp), -119.44% in FY2019 (+94.18 pp) and -213.62% in FY2018 (+133.10 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Aptevo Therapeutics | 2.71 Mn | -64.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -172.41% |
| Dec 31, 2021 | -103.25% |
| Sep 30, 2021 | -143.90% |
| Jun 30, 2021 | -174.37% |
| Mar 31, 2021 | -272.37% |
| Dec 31, 2020 | -272.95% |
| Sep 30, 2020 | -406.43% |
| Jun 30, 2020 | -1,373.78% |
| Dec 31, 2019 | -81.97% |
| Sep 30, 2019 | -121.11% |
| Jun 30, 2019 | -167.43% |
| Mar 31, 2019 | -154.61% |
| Dec 31, 2018 | -204.63% |
| Sep 30, 2018 | -197.97% |
| Jun 30, 2018 | -173.51% |
| Mar 31, 2018 | -317.22% |
| Dec 31, 2017 | -592.09% |
| Sep 30, 2017 | -147.00% |
| Jun 30, 2017 | -390.64% |
| Mar 31, 2017 | -527.08% |
API Access
Aptevo Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();